GlassScriptPhysician profile
Joseph Chase Purnell
NPI 1629422571
$1,409.09
in general payments reported to CMS, 2019-2025
14 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $192 · 2021: $52.11 · 2022: $258 · 2023: $227 · 2024: $350 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.27 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $334.10 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $167.66 | 2023-2025 | Ilumya |
| Abbvie INC. | $166.84 | 2020-2023 | |
| Leo Pharma INC. | $157.21 | 2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $139.42 | 2022-2023 | |
| Organogenesis INC. | $106.94 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $102.02 | 2021-2024 | Libtayo |
| Ucb, INC. | $69.15 | 2022-2025 | Bimzelx |
| Genzyme Corporation | $64.03 | 2022-2025 | |
| Biowound Solutions, INC. | $23.84 | 2025 | Bio-Connekt |
| Mimedx Group, INC. | $21.06 | 2024 | |
| Galderma Laboratories, L.P. | $19.20 | 2024 | |
| Incyte Corporation | $18.89 | 2024 | Opzelura |
| Genentech USA, INC. | $18.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Purnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.